Reilly Financial Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Reilly Financial Advisors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$12K	Hold	244	–	–	﹤0.01%	692
2021 Q3	$16K	Hold	244	–	–	﹤0.01%	576
2021 Q2	$18K	Hold	244	–	–	﹤0.01%	575
2021 Q1	$18K	Hold	244	–	–	﹤0.01%	565
2020 Q4	$18K	Hold	244	–	–	﹤0.01%	519
2020 Q3	$13K	Hold	244	–	–	﹤0.01%	533
2020 Q2	$16K	Hold	244	–	–	﹤0.01%	496
2020 Q1	$15K	Hold	244	–	–	﹤0.01%	482
2019 Q4	$21K	Hold	244	–	–	﹤0.01%	498
2019 Q3	$18K	Hold	244	–	–	﹤0.01%	538
2019 Q2	$21K	Hold	244	–	–	﹤0.01%	528
2019 Q1	$26K	Hold	244	–	–	﹤0.01%	471
2018 Q4	$21K	Hold	244	–	–	﹤0.01%	485
2018 Q3	$24K	Hold	244	–	–	﹤0.01%	516
2018 Q2	$28K	Hold	244	–	–	﹤0.01%	424
2018 Q1	$24K	Hold	244	–	–	﹤0.01%	443
2017 Q4	$26K	Sell	244 -19	-7%	-$2.09K	﹤0.01%	451
2017 Q3	$30K	Hold	263	–	–	﹤0.01%	400
2017 Q2	$29K	Hold	263	–	–	﹤0.01%	416
2017 Q1	$31K	Hold	263	–	–	0.01%	387
2016 Q4	$28K	Hold	263	–	–	﹤0.01%	384
2016 Q3	$29K	Hold	263	–	–	0.01%	343
2016 Q2	$38K	Hold	263	–	–	0.01%	289
2016 Q1	$38K	Hold	263	–	–	0.01%	432
2015 Q4	$41K	Hold	263	–	–	0.01%	422
2015 Q3	$38K	Buy	+263	New	+$36.8K	0.01%	436
2015 Q2	–	Sell	-263	Closed	-$37K	–	1438
2015 Q1	$37K	Hold	263	–	–	0.01%	486
2014 Q4	$39K	Sell	263 -37	-12%	-$5.44K	0.01%	298
2014 Q3	$46K	Hold	300	–	–	0.01%	272
2014 Q2	$43K	Hold	300	–	–	0.01%	287
2014 Q1	$33K	Hold	300	–	–	0.01%	344
2013 Q4	$30K	Sell	300 -100	-25%	-$8.67K	0.01%	326
2013 Q3	$31K	Hold	400	–	–	0.01%	291
2013 Q2	$23K	Buy	+400	New	+$23.6K	0.01%	335

Other funds holding TARO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Reilly Financial Advisors's TARO Position: Q4 2021 in Review

Reilly Financial Advisors held its Taro Pharmaceutical Industries Ltd. (TARO) position steady in Q4 2021 at 244 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #692.

Reilly Financial Advisors first reported a position in TARO in Q2 2013 and has held it in 34 quarters since. The position peaked at $46K in Q3 2014. 71 funds tracked by Wall St. Rank hold TARO as of Q4 2021.

Reilly Financial Advisors held 244 shares of Taro Pharmaceutical Industries Ltd. worth $12K as of Q4 2021.
Reilly Financial Advisors left its Taro Pharmaceutical Industries Ltd. share count unchanged in Q4 2021.
Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #692 holding.
Reilly Financial Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and has held it in 34 quarters since.
Reilly Financial Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $46K in Q3 2014.
71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.